Boothbay Fund Management, LLC Neuronetics, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.73 - $4.81 $40,701 - $113,164	23,527 Added 14.52%	185,600 $334,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $385,086 - $689,707	143,689 Added 781.6%	162,073 $771,000
Q4 2023 Feb 14, 2024	BUY	$1.05 - $2.9 $19,303 - $53,313	18,384 New	18,384 $53,000
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $84,529 - $134,533	-29,764 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $115,186 - $196,144	29,764 New	29,764 $133,000
Q1 2021 May 17, 2021	SELL	$10.6 - $21.27 $137,800 - $276,510	-13,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.95 - $11.45 $64,350 - $148,850	13,000 New	13,000 $144,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.